dr. Wouter Boon
W.P.C.Boon@uu.nl
Gegenereerd op 2018-09-23 10:34:48


Profile

Wouter Boon is assistant professor in Innovation and life sciences. His research in the field of innovation studies focuses on the dynamics and governance of emerging technologies in science-based sectors, such as life sciences and healthcare. 

The theoretical focus of his work is on the role of user innovations, user-producer interactions, regulation and knowledge production in emerging technology fields.

In this context he conducted research projects on governance of emerging health technologies (e.g. on the future of genetic testing), technology transfer practices in academic hospitals, regulation of pharmaceutical and medical device products (e.g. reimbursement and pharmacovigilance), patient participation in innovation processes, and public-private partnerships in R&D programmes aimed at the grand challenges.

He teaches, amongst others, courses about management of life sciences innovations and sustainable drug development.

Strategic themes / Focus areas
Scientific expertise
dynamics of innovation
lifesciences innovations
rare diseases and orphan drugs
Gegenereerd op 2018-09-23 10:34:48
Curriculum vitae

2013 – now

Assistant professor at the Innovation Studies Group (Utrecht University) on Innovation and life sciences.

2011 – 2013

Researcher at the Rathenau Institute on user-producer interactions in large-scale research programmes, knowledge co-creation, societal valorisation of research.

2010 – 2011

Researcher for the Steering Committee on Orphan drugs on the project about (cost)effectiveness research on orphan drugs in the Netherlands.

2009 – 2011

Researcher on the project “New modes of governing pharmacovigilance”, studying accelerated approval of pharmaceutical products at the Innovation studies group, Utrecht University.

2009

Researcher/consultant at Dialogic Innovation & interaction.

2008 – 2010

Assistant professor at the Athena Institute for research on innovation and communication in health and life sciences (VU University Amsterdam).

2004 – 2008

PhD-student on the project “User-producer interaction in pharmacogenomics innovations” at the Innovation studies group, Utrecht University.

2003 – 2004

Researcher at the Transport policy and Logistics, Faculty of Technology, Policy and Management, Delft University of Technology.

Gegenereerd op 2018-09-23 10:34:48
All publications
  2018 - Scholarly publications
Boon, Wouter & Edler, Jakob (01.08.2018). Demand, challenges, and innovation - Making sense of new trends in innovation policy. Science and Public Policy, 45 (4), (pp. 435-447).
Boon, Wouter & Van Wee, Bert (2018). Influence of 3D printing on transport - a theory and experts judgment based conceptual model. Transport Reviews, 38 (5), (pp. 556-575) (20 p.).
Edler, Jakob & Boon, Wouter P (01.08.2018). The next generation of innovation policy: Directionality and the role of demand-oriented instruments’ - Introduction to the special section. Science and Public Policy, 45 (4), (pp. 433-434).
Moors, Ellen H.M., Kukk Fischer, Piret, Boon, Wouter P.C., Schellen, Frank & Negro, Simona O. (2018). Institutionalisation of markets: The case of personalised cancer medicine in the Netherlands. Technological Forecasting and Social Change, 128, (pp. 133-143).
Münzel, K.L., Boon, W.P.C., Frenken, K. & Vaskelainen, T. (2018). Carsharing business models in Germany - characteristics, success and future prospects. Information Systems and e-Business Management, 16 (2), (pp. 271-291).
Robinson, Douglas K.R., Lagnau, Axel & Boon, Wouter P.C. (01.01.2018). Innovation pathways in additive manufacturing - Methods for tracing emerging and branching paths from rapid prototyping to alternative applications. Technological Forecasting and Social Change
te Kulve, Haico, Boon, Wouter, Konrad, Kornelia & Schuitmaker, Tjerk Jan (2018). Influencing the direction of innovation processes - The shadow of authorities in demand articulation. Science and Public Policy, 45 (4), (pp. 455-467).
Van Oers, Laura M., Boon, W. P.C. & Moors, Ellen H.M. (2018). The creation of legitimacy in grassroots organisations. A study of Dutch community supported agriculture. Environmental Innovation and Societal Transitions
  2017 - Scholarly publications
Boon, W.P.C., Evers, G.W. & Hoekman, J. (2017). Research-based innovation activities on rare diseases in the Netherlands. Utrecht / Den Haag: Utrecht University / ZonMW.
Kivimaa, Paula, Boon, Wouter & Antikainen, Riina (01.10.2017). Commercialising university inventions for sustainability - A case study of (non-)intermediating 'cleantech' at Aalto University. Science and Public Policy, 44 (5), (pp. 631-644) (14 p.).
  2016 - Scholarly publications
Boon, W.P.C. (09.06.2016) Chair 2016 Eu-SPRI Annual Conference, “Exploring New Avenues for Innovation and Research Policies”, Lund, Sweden (07.06.2016 - 10.06.2016) Chair of session 6B, Innovation and Medical Application (II)
Boon, Wouter P C & Bakker, Sjoerd (01.03.2016). Learning to shield - Policy learning in socio-technical transitions. Environmental Innovation and Societal Transitions, 18, (pp. 181-200) (20 p.).
de Vries, Gerben, Boon, Wouter & Peine, A. (2016). User-led innovation in civic energy communities. Environmental Innovation and Societal Transitions, 19, (pp. 51-65) (15 p.).
  2015 - Scholarly publications
Arentshorst, Marlous E., de Cock Buning, Tjard, Boon, Wouter P. C. & Broerse, Jacqueline E. W. (01.12.2015). ‘Prospecting responsible technology paths: Management options for an appropriate societal embedding of medical neuroimaging’. Science and Public Policy, 42 (6), (pp. 775-788) (14 p.). 10.1093/scipol/scv004.
Boon, W.P.C. (04.06.2015) Invited speaker First International Workshop on the Sharing Economy, Utrecht (04.06.2015 - 05.06.2016)
Boon, W.P.C. (04.06.2015) Member of programme committee First International Workshop on the Sharing Economy, Utrecht (04.06.2015 - 05.06.2016) Member of the Scientific committee of the First International Workshop on the Sharing Economy, Utrecht
Boon, W.P.C. (13.07.2015) Invited speaker International Open and User Innovation Conference Lissabon (13.07.2015 - 15.07.2015)
Boon, W.P.C. (13.07.2015) Invited speaker International Open and User Innovation Conference Lissabon (13.07.2015 - 15.07.2015)
Boon, W.P.C. (26.08.2015) Invited speaker International Sustainability Transitions Conference Brighton (26.08.2015 - 28.08.2015)
Boon, W.P.C. () Invited speaker Manchester Institute of Innovation Research Co-creation to address grand societal challenges. Seminar series of the Manchester Business School, Manchester Institute of Innovation Research, Manchester, UK
Boon, W.P.C. (10.06.2015) Invited speaker EU-SPRI Conference 2015 Helsinki (10.06.2015 - 12.06.2015) Dealing with conflicting demands in emerging technologies when public and private users collide. Presentation at Eu-SPRI Conference, Helsinki
Boon, W.P.C. (10.06.2015) Chair Eu-SPRI Conference (10.06.2015 - 12.06.2015) Session organised about ‘demand-based innovation policy’ together witth prof. Jakob Edler of Manchester Business School during Eu-SPRI Conference 2015
Boon, W.P.C. (10.06.2015) Invited speaker EU-SPRI Conference 2015 Helsinki (10.06.2015 - 12.06.2015) Intermediation for eco-innovations: Aalto Centre for Entrepreneurship in the context of a university innovation ecosystem. Presentation at Eu-SPRI Conference, Helsinki
Boon, W.P.C. (14.09.2015) Invited speaker Utrecht University Opening innovation processes – the role of users. Invited presenter at Seminar ‘Just what is “open” about open societies?’ of the Utrecht University strategic theme ‘Institutions’ (2015)
Boon, W.P.C. (10.06.2015) Invited speaker EU-SPRI Conference 2015 Helsinki (10.06.2015 - 12.06.2015) The missing links. Demand based policy making and instruments in the context of mission orientation. Presentation at Eu-SPRI Conference, Helsinki
Boon, W.P.C. (26.11.2015) Participant WTMC Dissertation Day (2015) Utrecht (26.11.2015) Senior discussant at the WTMC Dissertation Day (2015)
Boon, W.P.C., Martins, Luis & Koopmanschap, Marc (2015). Governance of conditional reimbursement practices in the Netherlands. Health Policy, 119 (2), (pp. 180-185) (6 p.). Copyright © 2014 Elsevier Ireland Ltd. All rights reserved..
Boon, Wouter P.C., Aarden, Erik & Broerse, Jacqueline E.W. (2015). Path creation by public agencies — The case of desirable futures of genomics. Technological Forecasting and Social Change, 99, (pp. 67-76) (10 p.).
De Haan, Freek, Onyamboko, Marie A., Fanello, Caterina I., Woodrow, Charles J., Lubell, Yoel, Boon, Wouter P. C. & Dondorp, Arjen M. (15.12.2015). Exploring health practitioners' acceptability of a prospective semi-quantitative pfHRP2 device to define severe malaria in the Democratic Republic of Congo. Malaria Journal, 14 (1).
Ebbers, Hans C, Langedijk, Joris, Bouvy, Jacoline C, Hoekman, Jarno, Boon, Wouter P C, de Jong, Jean Philippe & De Bruin, Marie L (25.07.2015). An analysis of marketing authorisation applications via the mutual recognition and decentralised procedures in Europe. European Journal of Clinical Pharmacology, 71 (10).
Hoekman, J, Boon, Wouter, Bouvy, J C, Ebbers, H C, de Jong, J P & De Bruin, M L (2015). Use of the conditional marketing authorization pathway for oncology medicines in Europe. Clinical Pharmacology and Therapeutics, 98 (5), (pp. 534-541) (8 p.). © 2015, The American Society for Clinical Pharmacology and Therapeutics..
  2015 - Popularising publications
Boon, W.P.C. (14.04.2015) Invited speaker RRI Tools Conference Lisbon (14.04.2015) Co-creation of knowledge: Knowledge for Climate. Invited presentation at RRI Tools Conference, Lisbon, Portugal
Boon, W.P.C. (16.03.2015) Invited speaker Dutch representative organisation of biotechnology companies HollandBio Conditional regulation of orphan drugs. Invited presentation at Seminar on innovating in the field of orphan drugs organised by the Dutch representative organisation of biotechnology companies HollandBio (2015)
  2014 - Scholarly publications
Boon, W.P.C. (27.11.2014) Invited speaker International Conference on Future-Oriented Technology Analysis, Brussel) Brussels (27.11.2014 - 28.11.2014)
Boon, W.P.C. (26.08.2014) Invited speaker International Sustainability Transitions Conference Utrecht (26.08.2014 - 29.08.2016)
Boon, W.P.C. () Organiser 2014 Eu-SPRI Annual Conference Manchester (18.06.2014 - 20.06.2014) Organiser Session : ‘Smart governance of emerging health technologies’, at 2014 EU-SPRI Annual Conference, Manchester, UK
Boon, W.P.C. () Invited speaker 2014 Eu-SPRI Annual Conference Manchester (18.06.2014 - 20.06.2014) Diffusion of user innovation – case of off-label drugs, presentation at 2014 EU-SPRI Annual Conference, Manchester, UK
Boon, W.P.C. () Organiser EASST 2014 Conference Torun (17.09.2014 - 19.09.2014) Organiser Session : ‘coproduction of emerging biomedical technologies’, at EASST 2014 Conference, Torun, Poland
Boon, W.P.C. (23.09.2014) Invited speaker International workshop ‘Organisation of research programmes on climate change’ Rotterdam (23.09.2014)
Boon, W.P.C., Bouvy, J.C., Broekmans, André W, de Bruin, Marie L., Ebbers, H.C., Hoekman, J., de Jong, J.P., Koopmanschap, Marc A., Langedijk, J. & Stolk, P. (2014). Improving the EU system for the marketing authorisation of medicines - Learning from regulatory practice. (158 p.). Leiden: Escher – The TI Pharma Platform for Regulatory Innovation.
Boon, W.P.C., Chappin, Maryse & Perenboom, Jaap (01.06.2014). Balancing divergence and convergence in transdisciplinary research teams. Environmental Science and Policy, 40, (pp. 57-68) (12 p.).
Boon, W.P.C., Moors, Ellen H M & Meijer, Albert J. (01.05.2014). Exploring dynamics and strategies of niche protection. Research Policy, 43 (4), (pp. 792-803) (12 p.).
Hessels, Laurens K., Wardenaar, Tjerk, Boon, W.P.C. & Ploeg, Matthias (2014). The role of knowledge users in public-private research programs - An evaluation challenge. Research Evaluation, 23 (2), (pp. 103-116) (14 p.).
  2014 - Popularising publications
Boon, W.P.C. (02.09.2014) Invited speaker Dutch innovative pharmaceutical companies Nefarma Feitenkaart Geneesmiddelenonderzoek 2014, invited presentation at Dutch innovative pharmaceutical companies Nefarma
Boon, W.P.C. () Invited speaker European Medicines Agency Invited presentation at European Medicines Agency, meeting on ‘Towards a learning regulatory system: how to address current regulatory challenges’, London, UK
Boon, W.P.C. (2014) Invited speaker Top Institute Pharma Invited presentation at Top Institute Pharma Annual Research Day 2014
Boon, W.P.C. (2014) Invited speaker Seminar on ‘Drugs in drinking water’ as part of a project together with KWR Water research, UMC Utrecht, TU Delft (01.03.2014) Invited speaker during eminar on ‘Drugs in drinking water’ as part of a project together with KWR Water research, UMC Utrecht, TU Delft
Boon, W.P.C. (23.01.2014) Invited speaker Ministry of Infrastructure and the Environment Kenniscoproductie voor de grote  maatschappelijke vraagstukken, invited lecture on knowledge co-production at the Ministry of infrastructure and the Environment
Boon, W.P.C. () Invited speaker European Federal Association for Pharmaceutical Industry & Association (EFPIA) Use of the conditional marketing authorisation pathway for oncology medicines, invited speaker European Federal Association for Pharmaceutical Industry & Association (EFPIA), Brussels
Boon, W.P.C. (26.08.2014) Invited speaker EU-DG Sanco meeting (26.08.2014) Use of the conditional marketing authorisation pathway for oncology products, presentation for EU-DG Sanco meeting
Boon, W.P.C. (13.05.2014) Invited speaker TI Pharma/Escher stakeholder workshop “Towards a Learning System: How to Address Current Regulatory Challenges?” (13.05.2014) Use of the conditional marketing authorisation pathway for oncology products”, speaker at the TI Pharma/Escher stakeholder workshop “Towards a Learning System: How to Address Current Regulatory Challenges?”
Boon, W.P.C. (18.09.2014) Invited speaker The Organisation for Professionals in Regulatory Affairs (TOPRA) Use of the conditional marketing authorisation pathway for oncology medicines, invited speaker at The Organisation for Professionals in Regulatory Affairs (TOPRA), Workshop on improving efficiency within the current regulatory system, Brussels, Belgium
  2013 - Scholarly publications
Boon, W.P.C. (2013) Invited speaker Invited speaker at Workshop Promisomics (01.01.2013) Demand articulation in large-scale R&D programs
Boon, W.P.C. (26.11.2013) Invited speaker Presentation at the Workshop "Constructing and contesting spaces for low-carbon energy innovation" Eindhoven, The Netherlands (26.01.2013) Learning to shield Regulatory learning in sociotechnical tranistions
Meijer, Albert, Boon, Wouter & Moors, Ellen (2013). Stakeholder engagement in pharmaceutical regulation - Connecting technical expertise and lay knowledge in risk monitoring. Public Administration, 91 (3), (pp. 696-711) (16 p.).
  2013 - Professional publications
Boon, W.P.C. (2013). Vervroegde toelating van griepvaccins - tussen vaart en veiligheid. Podium voor Bio-ethiek, 20 (1), (pp. 33-36) (4 p.).
Boon, W.P.C. & Horlings, E. (2013). Kenniscoproductie voor de grote maatschappelijke vraagstukken. (130 p.). Den Haag, The Netherlands: Rathenau Instituut, Project: Faciliteren van kenniscocreatie.
  2012 - Professional publications
Boon, Wouter, Smit, Cees, Evers, M.P.J., Meyboom, Ronald H. B. & Visser, Ele (2012). Patient participation in clinical research: societal responsible drug development. Pharmaceutisch Weekblad, 25, (pp. 14-18).
  2011 - Scholarly publications
Boon, W.P.C., Moors, E.H.M., Kuhlmann, S. & Smits, R.E.H.M. (2011). Demand articulation in emerging technologies: intermediary user organizations as co-producers?. Research Policy, 40 (2), (pp. 242-252) (11 p.).
Boon, Wouter P C, Moors, Ellen H M, Kuhlmann, Stefan & Smits, Ruud E H M (01.03.2011). Demand articulation in emerging technologies - Intermediary user organisations as co-producers?. Research Policy, 40 (2), (pp. 242-252) (11 p.).
Moors, E.H.M., Boon, W.P.C., Nahuis, R. & Vandeberg, R.L.J. (2011). User-Producer Interactions in Emerging Pharmaceutical and Food Innovations. In F. Flowers & F. Henwood (Eds.), Perspectives on User Innovation (pp. 161-188) (28 p.). London, UK: Imperial College Press.
Nahuis, Roel & Boon, Wouter P. C. (2011). The impact of patient advocacy - the case of innovative breast cancer drug reimbursement. Sociology of Health and Illness, 33 (1), (pp. 1-15) (15 p.).
Roelofsen, Anneloes, Boon, Wouter P C, Kloet, Roy R. & Broerse, Jacqueline E W (01.04.2011). Stakeholder interaction within research consortia on emerging technologies - Learning how and what?. Research Policy, 40 (3), (pp. 341-354) (14 p.).
  2011 - Professional publications
Boon, Wouter (2011). Doelmatigheidsonderzoek weesgeneesmiddelen – analyse en toekomstperspectief. Stuurgroep Weesgeneesmiddelen.
  2010 - Scholarly publications
Boon, W. P C, Moors, E. H M, Meijer, A. & Schellekens, H. (01.12.2010). Conditional approval and approval under exceptional circumstances as regulatory instruments for stimulating responsible drug innovation in Europe. Clinical Pharmacology and Therapeutics, 88 (6), (pp. 848-853) (6 p.).
Boon, W.P.C. (27.05.2010) Invited speaker Presentation at the 3rd International Conference Ten years after - Mapping the societal landscape of genomics - applying for the Urban zone Tropenmuseum Amsterdam, The Netherlands (27.01.2010) New modes of governing pharmacovigilance for genomics-based drugs
Boon, W.P.C. (28.10.2010) Invited speaker Presentation for International Conference Tentative Governance University Twente, Enschede, The Netherlands (28.01.2010) New Modes of Governing Pharmacovigilance: A contribution to responsible innovation
Boon, W.P.C. (26.05.2010) Invited speaker Paper presented at Wageningen International Conference on Chain and Network Management Wageningen, The Netherlands (26.01.2010) Positioning intermediary organisations in innovation
Boon, W.P.C. (21.06.2010) Invited speaker Presentation at the 19th Society for Risk Analysis (SRA) - Europe conference: Risk, Governance & Accountability King's College, London, UK (21.01.2010)
Boon, W.P.C. (28.10.2010) Invited speaker Paper presented at the international conference Tentative Governance in Emerging Science and Technology Enschede, The Netherlands (28.01.2010) Tentative positions: The positioning of intermediary organisations in the context of emerging technologies
Boon, W.P.C., Moors, E.H.M. & Meijer, A (02.09.2010). Governing ex-post drug risk surveillance: linking different epistemic cultures. EASST 010 - Practicing science and technology, performing the social Trento, Italy.
Boon, Wouter & Broekgaarden, Ria (2010). The role of patient advocacy organisations in neuromuscular disease R&D - The case of the Dutch neuromuscular disease association VSN. Neuromuscular Disorders, 20 (2), (pp. 148-151) (4 p.).
Boon, wOUTER & Heimeriks, Gaston (01.11.2010). Innovation in Europe - three questions. Nature, 468 (7322), (pp. 377).
Smit, C., Boon, W.P.C., Evers, M.P.J., Meyboom, R.H.B. & Visser, E. (2010). Tweede evaluatie WMO: Aandacht voor de positie van het prefpersonenlid en de patient is dringend gewenst. Tijdschrift voor Gezondheidsrecht, 4, (pp. 305-306) (2 p.).
van Lente, H., Boon, W.P.C. & Klerkx, L. (26.05.2010). Positioning of innovation intermediary organisations. 9th Wageningen International Conference on Chain and Network Management Wageningen, The Netherlands.
  2010 - Professional publications
Boerse, J., Boon, W.P.C. & vand er Kraats, J. (2010). Genomics/genetica en de zorgverzekering: Toekomstverkenning van de gevolgen voor de zorgverzekering. Unknown Publisher.
Boon, Wouter, Geurs, K. & Van Wee, Bert (2010). Deel 4: Sociale effecten van verkeer. In Bert van Wee & Jan-Anne Annema (Eds.), Verkeer en vervoer in hoofdlijnen – capita selecta Bussum: Uitgeverij Coutinho.
Smit, Cees, Boon, Wouter, Evers, M.P.J., Meyboom, Ronald H. B. & Visser, Ele (2010). Tweede evaluatie WMO: 'Aandacht voor de positie van het proefpersonenlid en de patient is dringend gewenst'. Tijdschrift voor Gezondheidsrecht, 2010 (4), (pp. 305-306).
  2010 - Popularising publications
Boon, W.P.C. (19.08.2010) Invited speaker Presentation at Helsinki Collegium for Advanced Studies, University of Helsinki. The role of users in teh intertwined changes of technology and practice (Helsinki, Finland) (19.01.2010) Demand articulation in emerging technologies: the role of Intermediary user organizations
  2010 - Other output
Moors, E.H.M., Meijer, A. J. & Boon, W.P.C. (21.01.2010). Organizer 1st Valorisation workshop NWO - Responsible Innovation project on New Modes of Governing Pharmacovigilance. Workshop.
Moors, E.H.M., Meijer, A. J. & Boon, W.P.C. (07.07.2010). Organizer 2nd Valorisation workshop NWO - Responsible Innovation project on New Modes of Governing Pharmacovigilance. Workshop.
  2009 - Scholarly publications
Boon, W. P C & van Merkerk, Rutger O. (17.07.2009). Prospective positioning of industrial players - The case of theranostics. Technology Analysis and Strategic Management, 21 (4), (pp. 471-489) (19 p.).
Boon, W.P.C. (04.06.2009) Invited speaker Proceedings of the KSI conference on "Dynamics and Governance of Transitions to Sustainability" Amsterdam, The Netherlands (04.01.2009) Shared Value Development towards a Metropolitan Agriculture
Boon, W.P.C. & van Merkerk, R.O. (2009). Prospective positioning of industrial players: the case of theranostics. Technology Analysis and Strategic Management, 21 (4), (pp. 471-489) (19 p.).
Boon, Wouter (2009). Anticipating emerging genomics technologies: The role of patents and publication for research and policy strategies. Genomics, Society and Policy, 5 (2), (pp. 1-21) (21 p.).
Geurs, K.T., Boon, W.P.C. & van Wee, G.P. (2009). Social impacts of transport: literature review and the state of the practice of transport appraisal in the Netherlands and the United Kingdom. Transport Reviews, 29 (1), (pp. 69-90) (22 p.).
  2008 - Scholarly publications
Boon, W. P C, Moors, E. H M, Kuhlmann, Stefan & Smits, R. E H M (01.06.2008). Demand articulation in intermediary organisations - The case of orphan drugs in the Netherlands. Technological Forecasting and Social Change, 75 (5), (pp. 644-671) (28 p.).
Boon, W.P.C. (2008) Invited speaker NFK&U (15.01.2008) Belangenbehartiging door patientenorganisaties - de discussie over dure geneesmiddelen
Boon, W.P.C. (20.08.2008) Invited speaker Presentation at 4S/EASST Conference Acting with science, technology and medicine Rotterdam, The Netherlands (20.01.2008) Demand articulation in emerging genomics technologies: the role of patient organisations
Boon, W.P.C. (17.04.2008) Invited speaker Presentation at CSG Society & Genomics Conference Amsterdam, The Netherlands (17.01.2008) Demand articulation in emerging genomics technologies: the role of patient organisations
Boon, W.P.C. (01.10.2008) Invited speaker Abstract/paper for FTA Conference Sevilla, Spain (01.01.2008) Demand articulation in emerging genomics technologies: the role of patient organizations
Boon, W.P.C. (16.10.2008) Invited speaker Presentation at 3rd International Seville conference on Future-oriented Technology Analysis (FTA) Impacts and implications for policy and decisions making Sevilla, Spain (16.01.2008) Demand articulation in emerging technologies: Intermediary user organizations as loci for multiple stakeholder FTA?
Boon, W.P.C., Moors, E.H.M., Kuhlmann, S. & Smits, R.E.H.M. (2008). Demand articulation in intermediary organisations: The case of orphan drugs in the Netherlands. Technological Forecasting and Social Change, 75 (5), (pp. 644-671) (28 p.).
Boon, Wouter & Moors, Ellen (01.05.2008). Exploring emerging technologies using metaphors - A study of orphan drugs and pharmacogenomics. Social Science and Medicine, 66 (9), (pp. 1915-1927) (13 p.).
Moors, E.H.M., Boon, W.P.C., Nahuis, R. & Vandeberg, R. (10.10.2008). User-producer interactions in emerging pharmaceutical and food innovations. International Journal of Innovation Management, 12 (3), (pp. 459-487) (29 p.).
Smits, R.E.H.M. & Boon, W.P.C. (2008). The role of user in innovation in the pharmaceutical industry. Drug Discovery Today, 13 (7-8), (pp. 353-359) (7 p.).
Smits, Rudolf & Boon, W. P C (01.04.2008). The role of users in innovation in the pharmaceutical industry. Drug Discovery Today, 13 (7-8), (pp. 353-359) (7 p.).
  2007 - Scholarly publications
Boon, W.P.C. (24.06.2007) Invited speaker Sixth annual meeting of the Technology, Management and Policy graduate consortium Pittsburgh, USA (24.01.2007) Demand articulation in emerging technologies - a case of an intermediary organisation
Boon, W.P.C. (26.03.2007) Invited speaker Cesagen&CSG Genomics and Society conference London, UK (26.01.2007) Demand articulation in pharmacogenomics innovations - a case of an intermediary organisation
Boon, W.P.C. (2007) Member Onderzoeksschool Wetenschap (External organisation) Advisory PhD-member of the board
Boon, W.P.C. (19.09.2007) Invited speaker Conference on pharmaceutical policy analysis Zeist, The Netherlands (19.01.2007) Patient advocacy and incomplete emerging pharmaceutical technologies
van Merkerk, Rutger O. & Boon, Wouter P C (01.09.2007). Industry strategies on theranostics - Need for structural alignment. Drug discovery world, 8 (4), (pp. 61-69) (9 p.).
  2007 - Professional publications
van Merkerk, R.O. & Boon, W.P.C. (2007). Industry strategies on theranostics: need for structural alignment. Drug discovery world, (pp. 61-69) (9 p.).
  2006 - Scholarly publications
Roelofsen, A. & Boon, W.P.C. (2006). Exploring visions as technologies emerge. In W. Vroom (Eds.), Genomics in society, from intentions to implementations The Second Corsage winter meeting.
  2005 - Scholarly publications
Boon, W.P.C. (16.12.2005) Invited speaker Corsage workshop Genomics and society: chances for true love? Utrecht, the Netherlands (16.01.2005)
Boon, W.P.C. (16.12.2005) Participant Genomics and society: Chances for true love? (16.01.2005) Title: Genomics and society: Chances for true love?
Boon, W.P.C. (01.09.2005) Invited speaker NUGO conference Lucca, Italy (01.01.2005) Identifying innovation hot spots in nutrigenomics
Boon, W.P.C. (23.02.2005) Invited speaker INNOGEN International Conference on Evolution of the Life Science Industries Edinburgh, UK (23.01.2005) User-producer interactions in functional genomics innovations
  2004 - Scholarly publications
Boon, W.P.C. & Cox, R. (2004). Policy benchmarking: demand oriented innovation policy in the Netherlands. Contribution to Policy Benchmarking: demand oriented innovation policy. Karlsruhe, the Netherlands: Fraunhofer Institute Systems and Innovation research.
  2004 - Other output
Boon, W.P.C. (2004). Sociale effecten van verkeer. Verkeer en vervoer in hoofdlijnen - capita selecta. In: B. van Wee en M. Dijst (red.).
^ top
Gegenereerd op 2018-09-23 10:34:50

Natuurwetenschap & Innovatiemanagement (Bachelor):

Management Life Sciences Innovations

Ziekte & Medicijnen

Innovatieproject 1

Bachelor thesis

 

Science and Innovation Management (Master):

Technology-related venturing

Master thesis

 

Young Innovators League

Gegenereerd op 2018-09-23 10:34:50
Full name
dr. W.P.C. Boon Contact details
Vening Meineszgebouw A

Princetonlaan 8a
Room 7.48
3584 CB  UTRECHT
The Netherlands


Phone number (direct) +31 30 253 2708
Gegenereerd op 2018-09-23 10:34:50
Last updated 07.02.2018